← Open Payments lookup

CHRISTOPHER MALYNOWSKI: Open Payments

NPI 1275622565 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,429 in 28 payments from 11 companies in 2025. Trend: 2023 $1,058 · 2024 $1,431 · 2025 $1,429

Food & beverage: $1,429
CompanyPaymentsAmount
Edwards Lifesciences Corporation5$736
Alnylam Pharmaceuticals Inc.6$189
SCPHARMACEUTICALS INC.1$113
Medtronic, Inc.1$89
PFIZER INC.5$87
Boehringer Ingelheim Pharmaceuticals, Inc.4$85
ABIOMED1$40
E.R. Squibb & Sons, L.L.C.2$31
Novartis Pharmaceuticals Corporation1$23
AstraZeneca Pharmaceuticals LP1$20

Products named: SAPIEN 3 Ultra RESILIA, AMVUTTRA, FUROSCIX, ELIQUIS, COREVALVE EVOLUT R, JARDIANCE, LEQVIO, FARXIGA.

Industry payments across NY — which companies pay providers there.